According to Manoj Kumar Bharti, Ambassador Extraordinary and Plenipotentiary of India to Belarus, India companies are ready to invest in pharmaceutical production in Belarus.
India has world renowned capacity in producing low cost, high quality bulk and generic drugs. Supply of such drugs and investment in producing pharmaceutical products in Belarus through JV by Indian companies will provide win-win situation for both countries. Presently $700 million is the size of pharma market in Belarus and about 70% of the total requirement of Belarus is imported. Thus it will also help fulfill Belarus’ target of domestic production of 50 percent of all drugs required.
Manoj Kumar Bharti believes that Belarusian and Indian companies can ramp up cooperation in manufacturing and information technologies.
For more information about this article, click here for
If you are interested in finding out more about partnership model strategies, then join us at the 8th Annual BioPharma Asia Convention in Singapore March 23rd – 25th 2015.